The decision was influenced by the positive recommendation from the EMA’s Committee for Medicinal Products for Human Use.

Approves Merck’s CAPVAXIVE® (Pneumococcal 21-valent Conjugate Vaccine) for Prevention of Invasive Pneumococcal Disease and ...

Over 100 years ago, the gold mining industry of South Africa had a problem: too many workers were dying from pneumonia.

Merck & Co. has won approval from the European Commission of its Capvaxive pneumococcal disease vaccine for adults. The Rahway, N.J., drugmaker on Wednesday said the approval covers the 21-valent ...

Merck (MRK), known as MSD outside of the United States and Canada, announced that the European Commission, or EC, has approved CAPVAXIVE, or ...

These findings demonstrate that the capsular serotype and genetic background significantly impact pneumococcal growth kinetics. The resultant growth features likely depend on the interaction between ...

Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria--such as how they synthesise their protective capsules--is essential for developing new ...

Antibiotic-resistant bacteria is a serious public health threat. Understanding the biology of these bacteria -- such as how they synthesise their ...

Antibiotic-resistant bacteria are a serious public health threat. Understanding the biology of these bacteria—such as how ...

SINGAPORE: Antibiotic-resistant bacteria pose a significant threat to public health, and researchers from the Yong Loo Lin School of Medicine at the National Un ...

To protect your child, their doctor will give them the pneumococcal conjugate vaccine (PCV). "This is a great example of a ...

Novartis today announced that oral Fabhalta® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G), to reduce proteinuria, ...